Mandatory healthcare associated infection (HCAI) surveillance: data quality statement
- Public Health England
- Part of:
- Clostridium difficile: guidance, data and analysis, Staphylococcus aureus: guidance, data and analysis, and Escherichia coli (E. coli): guidance, data and analysis
- First published:
- 7 April 2016
Data quality statement for the mandatory surveillance of healthcare associated infection (HCAI).
PDF, 871KB, 38 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
This document describes many of the aspects of quality assurance (QA) surrounding the routine publication of data for the mandatory surveillance of HCAI (MRSA, MSSA, and E. coli bacteraemia and C. difficile infection).
We will review and update this statement annually, towards the end of each financial year.
Published: 7 April 2016